UK Archives - HealthQuill

The UK’s Medicines and Healthcare products Regulatory Agency has approved Novo Nordisk’s weight-loss drug to cut the risk of obesity and adults suffering from heart problems or stroke.

Novo Nordisk’s Wegovy gets UK regulator nod to treat heart risks

The UK’s Medicines and Healthcare products Regulatory Agency has approved Novo Nordisk’s weight-loss drug to cut the risk of obesity and adults suffering.

by HealthQuill
July 24, 2024
0 Comments

Antitrust regulators in the UK have cleared a $3.1 billion acquisition of Olink Holding AB by Thermo Fisher Scientific Inc., following an initial probe that began in May last year.

Drugs Medical Pharma

Thermo Fisher’s $3.1 billion buy of Olink gets UK competition regulators’ nod

Antitrust regulators in the UK have cleared a $3.1 billion acquisition of Olink Holding AB by Thermo Fisher Scientific Inc., following an initial.

by HealthQuill
July 8, 2024
0 Comments

British drugmaker, GSK Plc.’s multiple myeloma drug, Blenrep, reduced the risk of disease progression or death by about 50% when compared to a standard-of-care combination, according to the company.

Drugs Health Pharma

GSK’s blood cancer test drug halves risk of disease progression: Data

British drugmaker, GSK Plc.’s multiple myeloma drug, Blenrep, reduced the risk of disease progression or death by about 50% when compared to a.

by HealthQuill
June 3, 2024
0 Comments

Technology-based medical training has led to junior doctors avoiding the ward to stick to the electronic tablet — a healthcare crisis that will soon rear its head as doctors will not have real-world experience, an expert said.

Health Medical Pharma

Medical education in the UK inflicting ‘pervasive harm’ on students: Expert

Technology-based medical training has led to junior doctors avoiding the ward to stick to the electronic tablet — a healthcare crisis that will.

by HealthQuill
May 31, 2024
0 Comments

Britain’s Competition and Markets Authority (CMA) expressed concerns over Theramex's planned acquisition of Femoston and Duphaston stating it may reduce competition and choice for hormone replacement therapy (HRT) treatments in the country.

Drugs Health Pharma

Britain’s CMA raises concern over Theramex’s Femoston buy

HQ Team April 4, 2024: Britain’s Competition and Markets Authority (CMA) expressed concerns over Theramex’s planned acquisition of Femoston and Duphaston stating it.

by HealthQuill
April 4, 2024
0 Comments

British drugmaker GSK Plc., will pay $1.4 billion to acquire Anglo-American biopharmaceutical company Aiolos Bio Inc., which makes medicines to treat asthma.

Drugs Health Pharma

GSK Plc., to buy asthma drugmaker Aiolos Bio for $1.4 billion

HQ Team January 9, 2023: British drugmaker GSK Plc., will pay $1.4 billion to acquire Anglo-American biopharmaceutical company Aiolos Bio Inc., which makes.

by HealthQuill
January 9, 2024
0 Comments

The first human case of a new swine flu variant in the UK has been detected by the Health Security Agency during a polymerase chain reaction testing after the individual had respiratory illness.

Drugs Health Pharma

First new strain of swine flu detected in UK, probe on to track virus origins

HQ Team November 29, 2023: The first human case of a new swine flu variant in the UK has been detected by the.

by HealthQuill
November 29, 2023
0 Comments

The WHO has reclassified the Covid-19 virus Omicron BA.2.86 mutation as a “variant of interest” after the global health agency reported an 8.9% rise in global prevalence in cases arising in the UK, France and Sweden.

Drugs Health Pharma

Omicron mutant BA.2.86 reclassified as ‘variant of interest’ by WHO

HQ Team November 29, 2023: The WHO has reclassified the Covid-19 virus Omicron BA.2.86 mutation as a “variant of interest” after the global.

by HealthQuill
November 29, 2023
0 Comments

Chongqing Zhifei Biological Products, the largest Chinese vaccine company by revenue, will buy shingles vaccines from GSK Plc., worth $3 billion to distribute in the Asian country.

Drugs Health Pharma

China’s Zhifei in $3 billion distribution deal with GSK for shingles vaccine

HQ Team October 10, 2023: Chongqing Zhifei Biological Products, the largest Chinese vaccine company by revenue, will buy shingles vaccines from GSK Plc.,.